ID | Name | Number of studies | |
---|---|---|---|
CL_0000763 | myeloid cell | 51 | |
CL_0000556 | megakaryocyte | 13 |
Gene | Number of supported studies | Average coverage | Other major groups (express this gene) | Other cell types (express this gene) | |
---|---|---|---|---|---|
PPBP | 6 | 80% ± 19% | 0 | 1 | |
MPIG6B | 6 | 68% ± 22% | 0 | 1 | |
TREML1 | 6 | 54% ± 28% | 0 | 1 | |
GP9 | 6 | 80% ± 20% | 0 | 1 | |
PF4 | 6 | 73% ± 27% | 0 | 1 | |
ITGA2B | 6 | 77% ± 22% | 0 | 2 | |
TUBB1 | 6 | 70% ± 18% | 0 | 2 | |
GP1BA | 5 | 67% ± 23% | 0 | 1 | |
ACRBP | 4 | 37% ± 13% | 0 | 1 | |
H2BC11 | 3 | 31% ± 14% | 0 | 1 | |
PF4V1 | 3 | 36% ± 15% | 0 | 1 | |
GP6 | 3 | 39% ± 7% | 0 | 1 | |
CAPN1-AS1 | 3 | 32% ± 18% | 0 | 1 | |
H3C10 | 3 | 36% ± 14% | 0 | 1 | |
LY6G6F | 3 | 36% ± 20% | 0 | 1 | |
HPSE | 3 | 33% ± 10% | 0 | 1 | |
GFI1B | 3 | 45% ± 10% | 0 | 2 | |
TRIM58 | 3 | 43% ± 15% | 0 | 3 | |
GATA1 | 3 | 48% ± 10% | 0 | 4 | |
CMTM5 | 6 | 74% ± 22% | 1 | 4 | |
RGS18 | 6 | 80% ± 14% | 1 | 10 | |
CLEC1B | 5 | 78% ± 9% | 1 | 2 | |
ITGB3 | 4 | 54% ± 20% | 1 | 2 | |
F13A1 | 4 | 43% ± 21% | 1 | 8 | |
NFE2 | 4 | 37% ± 10% | 1 | 10 | |
PTCRA | 3 | 27% ± 12% | 1 | 2 | |
TMEM40 | 6 | 58% ± 24% | 2 | 5 | |
MARCHF2 | 4 | 33% ± 15% | 2 | 6 | |
MPP1 | 6 | 63% ± 25% | 3 | 19 | |
ESAM | 5 | 66% ± 17% | 3 | 10 |
GO_1903706 | Biological process | regulation of hemopoiesis |
GO_0043306 | Biological process | positive regulation of mast cell degranulation |
GO_0033623 | Biological process | regulation of integrin activation |
GO_0072126 | Biological process | positive regulation of glomerular mesangial cell proliferation |
GO_1990314 | Biological process | cellular response to insulin-like growth factor stimulus |
GO_0007320 | Biological process | insemination |
GO_0060319 | Biological process | primitive erythrocyte differentiation |
GO_0014909 | Biological process | smooth muscle cell migration |
GO_0045347 | Biological process | negative regulation of MHC class II biosynthetic process |
GO_0033028 | Biological process | myeloid cell apoptotic process |
GO_0034440 | Biological process | lipid oxidation |
GO_0019372 | Biological process | lipoxygenase pathway |
GO_0060055 | Biological process | angiogenesis involved in wound healing |
GO_0030222 | Biological process | eosinophil differentiation |
GO_0070493 | Biological process | thrombin-activated receptor signaling pathway |
GO_1905598 | Biological process | negative regulation of low-density lipoprotein receptor activity |
GO_0033033 | Biological process | negative regulation of myeloid cell apoptotic process |
GO_0007599 | Biological process | hemostasis |
GO_0032369 | Biological process | negative regulation of lipid transport |
GO_2000678 | Biological process | negative regulation of transcription regulatory region DNA binding |
GO_0038027 | Biological process | apolipoprotein A-I-mediated signaling pathway |
GO_1903053 | Biological process | regulation of extracellular matrix organization |
GO_0007044 | Biological process | cell-substrate junction assembly |
GO_0045653 | Biological process | negative regulation of megakaryocyte differentiation |
GO_0098880 | Biological process | maintenance of postsynaptic specialization structure |
GO_1905665 | Biological process | positive regulation of calcium ion import across plasma membrane |
GO_0007597 | Biological process | blood coagulation, intrinsic pathway |
GO_0030219 | Biological process | megakaryocyte differentiation |
GO_0010888 | Biological process | negative regulation of lipid storage |
GO_0010656 | Biological process | negative regulation of muscle cell apoptotic process |
Cell type name | megakaryocyte |
Synonyms | megacaryocyte megalocaryocyte megalokaryocyte |
Description | A large hematopoietic cell (50 to 100 micron) with a lobated nucleus. Once mature, this cell undergoes multiple rounds of endomitosis and cytoplasmic restructuring to allow platelet formation and release. |
Parent | CL_0000763 |